Literature DB >> 19396632

Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis.

Sergio Oliva Nascif1, Patrícia Molica, Silvia Regina Correa-Silva, Marcos Roberto Silva, Ana-Maria Judith Lengyel.   

Abstract

Thyrotoxicosis might alter the hypothalamic-pituitary-adrenal (HPA) axis. We evaluated the effects of ghrelin and GHRP-6 on the HPA axis in 20 hyperthyroid patients and in 9 controls. Mean basal cortisol (microg/dl) and ACTH (pg/ml) levels were higher in hyperthyroidism (cortisol: 10.7 +/- 0.7; ACTH: 21.5 +/- 2.9) compared to controls (cortisol: 8.1 +/- 0.7; ACTH: 13.5 +/- 1.8). In thyrotoxicosis Delta AUC cortisol values (microg/dl.90 min) after ghrelin (484 +/- 80) and GHRP-6 (115 +/- 63) were similar to controls (ghrelin: 524 +/- 107; GHRP-6: 192 +/- 73). A significant increase in Delta AUC ACTH (pg/ml x 90 min) after ghrelin was observed in thyrotoxicosis (4,189 +/- 1,202) compared to controls (1,499 +/- 338). Delta AUC ACTH values after GHRP-6 were also higher, although not significantly (patients: 927 +/- 330; controls: 539 +/- 237). In summary, our results suggest that ghrelin-mediated pathways of ACTH release might be activated by thyroid hormone excess, but adrenocortical reserve is maintained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396632     DOI: 10.1007/s11102-009-0181-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  38 in total

1.  The influence of the thyroid on adrenal cortical function.

Authors:  R E PETERSON
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

2.  Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat.

Authors:  P A Bennett; G B Thomas; A D Howard; S D Feighner; L H van der Ploeg; R G Smith; I C Robinson
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.

Authors:  Silvia Regina Correa-Silva; Sérgio Oliva Nascif; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men.

Authors:  Vittorio Coiro; Gloria Saccani-Jotti; Roberta Minelli; Andrea Melani; Bruna Milli; Guido Manfredi; Riccardo Volpi; Paolo Chiodera
Journal:  Neuroendocrinology       Date:  2005       Impact factor: 4.914

5.  The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

Authors:  M Korbonits; G Kaltsas; L A Perry; P Putignano; A B Grossman; G M Besser; P J Trainer
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats.

Authors:  T C Kamilaris; C R DeBold; E O Johnson; E Mamalaki; S J Listwak; A E Calogero; K T Kalogeras; P W Gold; D N Orth
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

8.  Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects.

Authors:  P Moghetti; R Castello; F Tosi; M G Zenti; C Magnani; A Bolner; L Perobelli; M Muggeo
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

9.  Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.

Authors:  A M Mozid; G Tringali; M L Forsling; M S Hendricks; S Ajodha; R Edwards; P Navarra; A B Grossman; M Korbonits
Journal:  Horm Metab Res       Date:  2003-08       Impact factor: 2.936

10.  Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans.

Authors:  S C Dumoulin; B P Perret; A P Bennet; P J Caron
Journal:  Eur J Endocrinol       Date:  1995-05       Impact factor: 6.664

View more
  4 in total

1.  Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.

Authors:  Patricia Molica; Sergio Oliva Nascif; Silvia Regina Correa-Silva; Larissa Bianca Paiva Cunha de Sá; José Gilberto Henriques Vieira; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

Review 2.  Clinical review: The human experience with ghrelin administration.

Authors:  Margaret C Garin; Carrie M Burns; Shailja Kaul; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

3.  Adrenocortical reserves in hyperthyroidism.

Authors:  Kemal Agbaht; Sevim Gullu
Journal:  Endocrine       Date:  2013-03-27       Impact factor: 3.633

4.  Relative Adrenocortical Insufficiency Following Radioactive Iodine Therapy for Graves' Disease: A Report of Two Cases.

Authors:  Hanxin Zhao; Yu Ruan
Journal:  Int J Gen Med       Date:  2021-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.